Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|July 9, 2021
Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trialBanu K Arun, Hyo S Han, Bella Kaufman, et al.Clinical Breast Cancer|July 8, 2026
A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast CancerAmeer Basta, Kyle Lien, Gabris Ni, et al.Contemporary Clinical Trials|May 22, 2026
Rationale and study protocol for a randomized controlled MIND diet feeding trial for breast cancer-related cognitive impairmentSylvia L Crowder, Bihe Hu, Aasha I Hoogland, et al.Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2021
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II StudyAntoinette R Tan, Gail S Wright, Anu R Thummala, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Relevance of Platinum-free Interval and <i>BRCA</i> Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g<i>BRCA</i> Advanced Breast Cancer (BROCADE3 Crossover)Shannon L Puhalla, Véronique Diéras, Banu K Arun, et al.Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.The Lancet. Oncology|October 3, 2019
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trialAntoinette R Tan, Gail S Wright, Anu R Thummala, et al.Pageof 6